Literature DB >> 659554

Quantitative gas-liquid chromatographic method for the determination of indomethacin in biological fluids.

R G Sibeon, J D Baty, N Baber, K Chan, M L Orme.   

Abstract

A sensitive and specific gas chromatographic method for the analysis of indomethacin has been developed. After extraction of the drug from blood or urine with ethylene dichrloride a derivative is formed with pentafluorobenzyl bromide. 5-Fluoro-indomethacin is used as an internal standard. The overall recovery of indomethacin is 85.1 +/- 2.3% and the method can detect 10 ng indomethacin in a 1 ml plasma or urine sample. No interference in the method is seen with some commonly used drugs. The method has been used to measure plasma indomethacin concentrations in 20 patients with rheumatoid arthritis, being treated with 25 mg indomethacin three times daily. The plasma concentration ranged from 168-596 ng/ml.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659554     DOI: 10.1016/s0021-9673(00)89871-4

Source DB:  PubMed          Journal:  J Chromatogr


  9 in total

Review 1.  Correlation plasma levels, NSAID and therapeutic response.

Authors:  J P Famaey
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

2.  The effects of indomethacin on serum gastrin concentrations.

Authors:  M L Orme; G J Dockray; N Baber; R G Sibeon; L D Halliday; T R Littler
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

3.  Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus.

Authors:  P Vert; G Bianchetti; F Marchal; P Monin; P L Morselli
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

4.  Clinical Pharmacokinetics of indomethacin.

Authors:  L Helleberg
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

5.  Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders.

Authors:  N Baber; L D Halliday; W J van den Heuvel; R W Walker; R Sibeon; J P Keenan; T Littler; M L Orme
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

6.  Plasma indomethacin assay by reversed-phase ion pair high pressure liquid chromatography.

Authors:  J H Jonkman; W J Van der Boon; R Schoenmaker; A Holtkamp
Journal:  Pharm Weekbl Sci       Date:  1983-12-16

7.  Indomethacin in rheumatoid arthritis: comparison of oral and rectal dosing.

Authors:  N Baber; R Sibeon; E Laws; L Halliday; M Orme; T Littler
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

8.  A clinical and pharmacokinetic study of indomethacin in standard and slow release formulations.

Authors:  K R Adams; L D Halliday; R G Sibeon; N Baber; T Littler; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

9.  Osmosin: its effect on plasma and synovial fluid kinetics of indomethacin.

Authors:  P D Fowler; P T Dawes
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.